Acurx Pharmaceuticals
ACXP
ACXP
26 hedge funds and large institutions have $1.15M invested in Acurx Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 0.39% → 0.42% (+0.03%)
52% less capital invested
Capital invested by funds: $2.41M → $1.15M (-$1.25M)
Holders
26
Holding in Top 10
–
Calls
$20K
Puts
$3K
Top Buyers
| 1 | +$48.8K | |
| 2 | +$39.4K | |
| 3 | +$27.7K | |
| 4 |
VF
Virtu Financial
New York
|
+$23K |
| 5 |
AA
ACT Advisors
Asheville,
North Carolina
|
+$17.3K |
Top Sellers
| 1 | -$85.1K | |
| 2 | -$33.8K | |
| 3 | -$19K | |
| 4 |
NS
NBC Securities
Birmingham,
Alabama
|
-$14.2K |
| 5 |
BlackRock
New York
|
-$2.13K |